Have a feature idea you'd love to see implemented?
Let us know!
GBIO Generation Bio Co
Price (delayed)
$0.88
Market cap
$58.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.19
Enterprise value
$128.75M
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent
Highlights
The gross profit has grown by 41% from the previous quarter
GBIO's revenue is up by 41% since the previous quarter
The net income has contracted by 17% YoY but it has grown by 8% from the previous quarter
Generation Bio's EPS has decreased by 11% YoY but it has increased by 8% from the previous quarter
The equity has shrunk by 55% YoY and by 10% QoQ
The quick ratio has contracted by 31% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of GBIO
Market
Valuations
Earnings
Shares outstanding
66.79M
Market cap
$58.78M
Enterprise value
$128.75M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.56
Price to sales (P/S)
3.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.93
Revenue
$18.58M
Gross profit
$18.58M
Net income
-$145.47M
EBIT
-$145.47M
EBITDA
-$140.39M
Free cash flow
-$104.21M
Per share
Balance sheet
Liquidity
EPS
-$2.19
EPS diluted
-$2.19
Free cash flow per share
-$1.56
Book value per share
$1.56
Revenue per share
$0.28
TBVPS
$3.73
Total assets
$248.78M
Total liabilities
$144.34M
Debt
$93.78M
Equity
$104.44M
Working capital
$161.09M
Debt to equity
0.9
Current ratio
6.34
Quick ratio
6.27
Net debt/EBITDA
-0.5
Margins
Efficiency
Dividend
EBITDA margin
-755.5%
Gross margin
100%
Net margin
-782.9%
Operating margin
-846.2%
Return on assets
-49.5%
Return on equity
-104.9%
Return on invested capital
-46.1%
Return on capital employed
-66.5%
Return on sales
-782.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GBIO stock price
How has the Generation Bio stock price performed over time
Intraday
-4.35%
1 week
-15.38%
1 month
-24.14%
1 year
-53.93%
YTD
-16.98%
QTD
-16.98%
Financial performance
How have Generation Bio's revenue and profit performed over time
Revenue
$18.58M
Gross profit
$18.58M
Operating income
-$157.25M
Net income
-$145.47M
Gross margin
100%
Net margin
-782.9%
Generation Bio's net margin has soared by 81% YoY and by 35% from the previous quarter
GBIO's operating margin has surged by 81% year-on-year and by 35% since the previous quarter
The gross profit has grown by 41% from the previous quarter
GBIO's revenue is up by 41% since the previous quarter
Growth
What is Generation Bio's growth rate over time
Valuation
What is Generation Bio stock price valuation
P/E
N/A
P/B
0.56
P/S
3.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.93
Generation Bio's EPS has decreased by 11% YoY but it has increased by 8% from the previous quarter
The P/B is 73% below the 5-year quarterly average of 2.1 and 63% below the last 4 quarters average of 1.5
The equity has shrunk by 55% YoY and by 10% QoQ
GBIO's price to sales (P/S) is 82% lower than its last 4 quarters average of 17.1
GBIO's revenue is up by 41% since the previous quarter
Efficiency
How efficient is Generation Bio business performance
Generation Bio's ROE has plunged by 122% YoY and by 13% from the previous quarter
Generation Bio's ROS has soared by 81% YoY and by 35% from the previous quarter
The ROA has plunged by 59% YoY and by 2.1% from the previous quarter
Generation Bio's ROIC has decreased by 27% YoY but it has increased by 5% from the previous quarter
Dividends
What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GBIO.
Financial health
How did Generation Bio financials performed over time
Generation Bio's total assets is 72% higher than its total liabilities
Generation Bio's total assets has decreased by 35% YoY and by 6% QoQ
The quick ratio has contracted by 31% YoY and by 14% from the previous quarter
Generation Bio's debt is 10% less than its equity
Generation Bio's debt to equity has surged by 165% YoY and by 11% QoQ
The equity has shrunk by 55% YoY and by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.